Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

This study has been completed.
Society of Family Planning
Bill and Melinda Gates Institute for Population and Reproductive Health
Rakai Health Sciences Program, Rakai, Uganda
Information provided by (Responsible Party):
Ronald Gray, Johns Hopkins Bloomberg School of Public Health Identifier:
First received: April 4, 2012
Last updated: March 15, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)